{"database":"EVA","file_versions":[],"scores":{"citationCount":0,"reanalysisCount":0,"viewCount":0,"searchCount":0},"additional":{"dataset_type":["Exome Sequencing"],"omics_type":["Genomics"],"submitter":["Federal State Budgetary Institution «Research Centre For Medical Genetics», Moscow, Russia"],"instrument_platform":["unspecified"],"species":["Homo Sapiens"],"full_dataset_link":["https://www.ebi.ac.uk/eva/?eva-study=PRJEB9857"],"repository":["EVA"],"name_synonyms":["Myelogenous Leukemias, Myelocytic, Myelogenous, leukemia, Chronic Myelocytic Leukemia, Chronic Granulocytic Leukemia, Granulocytic Leukemias, Complete Exome Sequencings, Philadelphia Positive, Chronic Myeloid Leukemia, Myeloid, Chronic Myelocytic, Exome, Ph1-Positive Myelogenous Leukemia, Myelocytic Leukemia, chronic granulocytic leukaemia, Philadelphia-Positive, Philadelphia-Positive Myeloid Leukemias, Leukemias, chronic, Fs(3)Sz11, Ph1-Positive, CML, Ph1-Positive Myeloid Leukemias, Exome Sequencing, chronic myelogenous, Chronic myelogenous leukemia, chronic myelogenous leukemia, Philadelphia-Positive Myeloid, Myeloid Leukemias, response to TKI, Whole Transcriptome, Transcriptome Sequencing, DmF2, Ph1 Positive, atypical, Philadelphia-Positive Myeloid Leukemia, Fs(3)Hor, Chronic Myelocytic Leukemias, lod, Chronic Granulocytic Leukemias, Chronic granulocytic leukemia, WES, Complete Transcriptome, DmelCG2684, chronic myeloid, Leukemia, Complete, Complete Transcriptome Sequencing, Exome Sequencings, Chronic Granulocytic, Chronic Myelogenous, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemias, Complete Exome Sequencing, Whole Transcriptome Sequencing, Granulocytic Leukemia, Ph1-Positive Myelogenous, Chronic Myelogenous Leukemias, Myelogenous Leukemia, Ph1-Positive Myeloid, NTef2, Lds, Sequencing, early, Granulocytic, Whole Exome, chronic granulocytic leukemia, Ph1-Positive Myelogenous Leukemias, Horka, chronic myelogenous leukaemia, Whole, CML - chronic Myelogenous Leukemia, Myeloid Leukemia, Myelocytic Leukemias, chronic myeloid leukaemia, Whole Exome Sequencing, CG2684, Ph1-Positive Myeloid Leukemia, Fs(3)Horka, Chronic, Transcriptome Sequencings, Complete Exome., Chronic Myeloid"],"description_synonyms":["Myelogenous Leukemias, Myelocytic, Chronic Myelocytic Leukemia, Chronic Granulocytic Leukemia, Philadelphia Positive, Product, Chronic Myeloid Leukemia, Myeloid, TKI inhibitor, Myelocytic Leukemia, chronic granulocytic leukaemia, Philadelphia-Positive Myeloid Leukemias, CML, chronic myelogenous, Kinase Inhibitors, Tyrosine Kinase Inhibitor, resistance, Pharmaceutical Product, Inhibitors, Ph1 Positive, atypical, Philadelphia-Positive Myeloid Leukemia, Low, DmF2, Fs(3)Hor, Chronic Myelocytic Leukemias, lod, Drugs, treatment, Chronic Granulocytic Leukemias, study, chronic myeloid, me75, DmelCG2684, Leukemia, TKI inhibitors, reference sample, Granulocytic Leukemia, tyrosine kinase inhibitors, Chronic Myelogenous Leukemias, Myelogenous Leukemia, NTef2, D17Mit170, T1, Granulocytic, drugs, Pharmaceuticals., protein tyrosine kinase inhibitors, Ph1-Positive Myelogenous Leukemias, medicine, Pharmaceutical, Clients, Myeloid Leukemia, Myelocytic Leukemias, disease management, Ph1-Positive Myeloid Leukemia, Therapies, Chronic, Preparation, tyrphostin, Controlled, Tyrosine Protein Kinase Inhibitors, Myelogenous, leukemia, Therapy, Products, Controlling, Granulocytic Leukemias, cou, Chronic Myelocytic, Ph1-Positive Myelogenous Leukemia, Philadelphia-Positive, Medications, Tl3, Tl2, Client, Leukemias, chronic, TKI Tyrosine Kinase Inhibitors, Fs(3)Sz11, Tyrosine, Ph1-Positive, Ph1-Positive Myeloid Leukemias, Lr, Chronic myelogenous leukemia, chronic myelogenous leukemia, Philadelphia-Positive Myeloid, Myeloid Leukemias, protein tyrosine kinase inhibitor, tyrphostins, Pharmaceutic, Chronic granulocytic leukemia, Chronic Granulocytic, Chronic Myelogenous, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemias, Pharmaceutic Preparations, Ph1-Positive Myelogenous, Ph1-Positive Myeloid, Lds, Treatments, Tyrosine Kinase, early, Drug, Preparations, chronic granulocytic leukemia, Patient, Therapeutic, Horka, chronic myelogenous leukaemia, CML - chronic Myelogenous Leukemia, chronic myeloid leukaemia, Bra, CG2684, Fs(3)Horka, Treatment, Pharmaceutical Products, Chronic Myeloid, Pharmaceutical Preparation"],"citation_count":["0"],"additional_accession":[]},"is_claimable":false,"name":"Prognostic factors of early response to TKI in chronic myeloid leukemia by whole exome sequencing","description":"Chronic myeloid leukemia can be well controlled by targeted tyrosine kinase inhibitors (TKI). However there is about 10% of patients with primary resistance or low efficacy of the therapy. In our study we found promissing new potential early prognostic markers and molecular targets for developing new drugs.  ","dates":{"publication":"2015-07-12"},"accession":"PRJEB9857","cross_references":{"TAXONOMY":["9606"]}}